Breaking News, Promotions & Moves

Pfizer Appoints Worldwide R&D Leaders

Ehlers to lead BioTherapeutics R&D and Lin named CSO of Rinat

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pfizer has made two strategic appointments in its Worldwide R&D organization effective immediately. Michael D. Ehlers, M.D., Ph.D., has been named group senior vice president and head of BioTherapeutics R&D and site head for Pfizer’s Cambridge and Boston, MA locations. Dr. Ehlers will report directly to Mikael Dolsten, M.D., Ph.D., president of Worldwide R&D.   Also, John Lin, M.D., Ph.D., has been appointed senior vice president and chief scientific officer of Rinat. Dr. Lin will re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters